Close
CDMO Safety Testing 2026
Novotech

Featured

Selecting an optimized stability plan for your injectable drug product

No matter the indication, molecule, or therapeutic area, every drug developer working on a parenteral medication needs to answer the same essential question: whatโ€™s the best approach to retaining the productโ€™s stability? The answer is critically important from your very...

Keeping The Risk of Packaging In Check With Kids Involved

In the pharmaceutical industry and other consumer markets that produce and sell hazardous substances, child-resistant packagingย has become an essential element of packaging design. As legislation and regulations increase all around the world and more firms take the moral pledge...

4 Trends Transforming the Never-Normal Future of Manufacturing

2021 Manufacturing Trends If 2020 was the year of disruption, 2021 is the year of adaptation. Download this trend brief to explore ways that manufacturers are adapting to change and evolving to stay competitive. What's Included: Embracing digitization. Liberating data. Balancing...

Vaccine Temperatures: Keeping it cool for COVID-19

With more vaccines being approved worldwide, maintaining the shipmentsโ€™ integrity throughout the delivery process is the most challenging hurdle for many logistics providers. Since the first COVID-19 vaccine was approved in December last year โ€“ Pfizer-BioNTechโ€™s mRNA vaccine โ€“ there...

Redefining interoperability in the digital age

From Amazon pharmacy to Apple Health to Epic and Cerner battles to digital drug companions, the state of healthcare interoperability has come alive with digital power. And the COVID-19 pandemic accelerated this ability making telehealth mainstream for most medical...

Delivery logistics is critical to COVID-19 vaccine availability

The opening months of 2021 have revealed the logistical and political intricacies of COVID-19 vaccine manufacturing and deployment. The unprecedented requirement of vaccinating the world against a single virus has demonstrated the power of modern medicine and logistics capabilities. The...

Novavax Completes Enrollment of PREVENT-19, COVID-19 Vaccine Pivotal Phase 3 Trial in the United States and Mexico

Novavax, Inc., a biotechnology company developing next-generation vaccines for serious infectious diseases, announced the complete enrollment of PREVENT-19, its pivotal Phase 3 study in the United States and Mexico to evaluate the efficacy, safety and immunogenicity of the companyโ€™s...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป